Hepatobiliary manifestations of inflammatory bowel disease

Gastroenterology Clinics of North America

Volumn 28, Issue 2, 1999, Pages 491-513

  Raj, V ^a   Lichtenstein, D R ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; COPPER; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PENICILLAMINE; URSODEOXYCHOLIC ACID;

CHOLANGITIS; CHOLELITHIASIS; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FATTY LIVER; HEPATITIS; HEPATOBILIARY DISEASE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; OSTEOPOROSIS; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; SIDE EFFECT; ULCERATIVE COLITIS;

EID: 0032981199     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70067-4     Document Type: Article

References (140)

1. K.M. Abu-Elmgad M. Malinchoc E.R. Dickson Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis Surg Gynecol Obstet 177 1993 335 344
2. Alberti-Florr J.J. De Medina M. L. Jeffers Elevated immunoglobulins and immune complexes in the bile of patients with primary sclerosing cholangitis Am J Gastroenterol 81 1986 325 328
3. A.L. Baker M.M. Kaplan R.A. Norton Gallstones in inflammatory bowel disease Am J Dig Dis 19 1974 109 112
4. V. Balan N.F. LaRusso Hepatobiliary disease in inflammatory bowel disease Gastroenterol Clin North Am 24 1995 647 669
5. K. Balasubramanian R.H. Wiesner La Russo N.F. Primary sclerosing cholangitis with normal alkaline phosphatase activity Gastroenterology 95 1988 1395 1398
6. T.H. Baron R.E. Koehler W.H. Rodgers Mast cell cholangiopathy: Another cause of sclerosing cholangitis Gastroenterology 109 1995 1677 1681
7. N.V. Bergasa E.A. Jones The pruritus of cholestasis Semin Liver Dis 13 1993 319 327
8. N.V. Bergasa T.L. Talbot D.W. Alling A controlled trial of naloxone infusions for the pruritus of chronic cholestasis Gastroenterology 1992 544 549
9. U. Beuers U. Spengler W. Kruis Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo controlled trial Hepatology 16 1992 707 714
10. R. Bleday E. Lee J. Jessurun Increased risk of early colorectal neoplasm after hepatic transplant in patients with inflammatory bowel disease Dis Colon Rectum 36 1993 908 912
11. K.M. Boberg K.E.A. Ludin E. Schrumph Etiology and pathogenesis in primary sclerosing cholangitis Scand J Gastroenterol 29 suppl 204 1994 47 58
12. Bodenheimer H.C. Jr N.F. LaRusso W.R. Thayer Eleveted circulating immune complexes in primary sclerosing cholangitis Hepatology 3 1983 150 154
13. B. Borkje K. Vetvik S. Odegaard Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative colitis Scand J Gastroenterol 20 1985 539 542
14. L. Brinch P. Teisberg E. Schrumph The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis Scand J Gastroenterol 17 1982 523 527
15. U. Broome H. Glaumann R. Hultcrantz Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis Scand J Gastroenterol 25 1990 54 58
16. U. Broome R. Olsson L. Loof Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis Gut 38 1996 610 615
17. J.L. Cameron H.A. Pitt M.J. Zinner Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis Ann Surg 207 1988 614 622
18. W.L. Campbell R. Sheng A.B. Zajko Intrahepatic biliary strictures after liver transplantation Radiology 191 1994 735 740
19. J.R. Cangemi Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis Gastroenterology 96 1989 790 794
20. J.P. Cello Acquired immunodeficiency syndrome cholangiopathy: Spectrum of disease Am J Med 86 1989 539 546
21. R.W. Chapman Role of immune factors in the pathogenesis of primary sclerosing cholangitis Semin Liver Dis 11 1991 1 4
22. R.W.G. Chapman B.A. Marborgh J.M. Rhodes Primary sclerosing cholangitis: A review of its clinical features, cholangiography, and hepatic histology Gut 21 1980 870 877
23. R.W. Chapman D.P. Jewell Primary sclerosing cholangitis—an immunologically mediated disease? West J Med 143 1985 193 195
24. R.W. Chapman P.M. Kelly A. Heryet Expression of HLA-DR antigens on bile duct epithelium on primary sclerosing cholangitis Gut 29 1988 422 427
25. R.W. Chapman Z. Verghese R. Gaul Association of primary sclerosing cholangitis with HLA B-8 Gut 24 1983 38 41
26. S. Cohen M. Kaplan L. Gottlieb Liver disease and gallstones in regional enteritis Gastroenterology 60 1971 237 245
27. H.O. Conn Transjugular intrahepatic portal-systemic shunt: The state of the art Hepatology 17 1993 148 158
28. A.E. Cowen M.G. Korman A.F. Hofmann Metabolism of lithocholate in healthy man: Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholyglycine, and their sulfates Gastroenterology 69 1975 59 66
29. J.S. Crippin K.D. Lindor Primary sclerosing cholangitis: Etiology and immunology Eur J Gastroenterol Hepatol 4 1992 261 265
30. K.M. Das M. Vecchi S. Sakamaki A shared and unique epitope(s) on human colon, skin and biliary epithelium detected by a monoclonal antibody Gastroenterology 98 1990 464 469
31. De Maria N. A. Colantoni E. Rosenbloom Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2 year period Hepatogastroenterology 43 1996 1472 1479
32. M.J. Dew A.H. Thompson R.N. Allain The spectrum of hepatic dysfunction in inflammatory bowel disease QJM 48 1979 113 115
33. E.R. Dickson P.A. Murtagh R.H. Wiesner Primary sclerosing cholangitis: Refinement and validation of survival models Gastroenterology 103 1992 1893 1901
34. P.T. Donaldson J.M. Farrant M.L. Wilkinson Dual association of HLA-DR2 and DR3 with primary sclerosing cholangitis Hepatology 13 1991 129 133
35. R.H. Duerr S.R. Targan C.J. Landers Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis Gastroenterology 100 1991 1385 1391
36. O. Epstein R.W.G. Chapman G. Lake-Bakaar The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis Gastroenterology 83 1982 1177 1182
37. J.M. Farrant K.M. Hayllar M.L. Wilkinson Natural history and prognostic variables in primary sclerosing cholangitis Gastroenterology 100 1991 1710 1717
38. M.P. Feith I.J. Klompmaker J.K. Maring Biliary reconstruction during liver transplantation in patients with primary sclerosing cholangitis Transplant Proc 29 1997 560 561
39. A.P. Ferrari D.R. Lichtenstein A. Slivka Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies Gastrointest Endosc 40 1994 140 145
40. K.A. Fleming The hepatobiliary pathology of primary sclerosing cholangitis Eur J Gastroenterol Hepatol 4 1992 266 271
41. A.A. Gaing J.M. Geders J.H. Siegel Endoscopic management of primary sclerosing cholangitis: Review and report of an open series Am J Gastroenterol 88 1993 2000 2008
42. C.F. Garagliano A.M. Lilienfield A.I. Mendeloff Incidence rates of liver cirrhosis and related diseases in Baltimore and selected areas of the United States J Chron Dis 32 1979 543 554
43. A.J. Greenstein H.D. Janowitz D.B. Sachar The extraintestinal complications of Crohn's disease and ulcerative colitis: A study of 700 patients Medicine 55 1976 401 412
44. J.R. Gross J. Ludwig R.H. Wiesner Abnormalities in tests of copper metabolism in primary sclerosing cholangitis Gastroenterology 89 1985 272 278
45. N. Grunnet H.H. Rasmussen U. Tage-Jensen Association of primary sclerosing cholangitis with HLA-DR52a? Tissue Antigens 38 1991 133 136
46. A. Harmatz Hepatobiliary manifestations of inflammatory bowel disease Med Clin North Am 78 1994 1387 1398
47. R.F. Harrison M.H. Davies J.M. Neuberger Fibrous and obliterative cholangitis in liver allografts: Evidence of recurrent primary sclerosing cholangitis? Hepatology 20 1994 356 361
48. J.E. Hay K.D. Lindor R.H. Wiesner The metabolic bone disease of primary sclerosing cholangitis Hepatology 14 1991 257 261
49. J.E. Hay R.H. Wiesner R.G. Shorter Primary sclerosing cholangitis and celiac disease: A novel association Ann Intern Med 109 1988 713 717
50. J.H. Helzberg J.M. Peterson J.L. Boyer Improved survival with primary sclerosing cholangitis: A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients Gastroenterology 92 1987 1869 1875
51. C.H. Hobson T.J. Butt D.M. Ferry Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis Gastroenterology 94 1988 1006 1013
52. R.T. Holzbach M.E. March M.R. Freedman Portal vein bile acids in patients with severe inflammatory bowel disease Gut 21 1980 428 435
53. T. Ismail I. Angrisani J.E. Powell Primary sclerosing cholangitis: Surgical options, prognostic variables and outcome Br J Surg 78 1991 564 567
54. G.K. Johnson J.E. Geenen R.P. Venu Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: A larger series and recommendations for treatment Gastrointest Endosc 37 1991 38 43
55. M.M. Kaplan S. Aroia S.H. Pincus Primary sclerosing cholangitis and low-dose oral pulse methotrexate Ann Intern Med 106 1987 231 235
56. A.H. Karheuser R.R. Dozois N.F. LaRusso Comparison of surgical treatment of ulcerative colitis associated with primary slcerosing cholangitis: Ileal pouch-anal anastomosis versus Brooke ileostomy Mayo Clin Proc 71 1996 748 756
57. M. Kaw W.B. Silverman M. Rabinovitz Biliary tract calculi in primary sclerosing cholangitis Am J Gastroenterol 90 1995 72 75
58. M.M. Kemeney H. Battifora D.W. Blayney Sclerosing cholangitis after continuous hepatic artery infusion of FUDR Ann Surg 202 1985 176 181
59. R. Klein J. Eisenburg P. Weber Significance and specificity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis Hepatology 14 1991 1147 1152
60. T.A. Knox M.M. Kaplan A double blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis Gastroenterology 106 1994 494 499
61. T.A. Knox M.M. Kaplan Treatment of primary sclerosing cholangitis with oral methotrexate Am J Gastroenterol 86 1991 546 552
62. K. Kono K. Ohnishi M. Omata Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic E. coli in rabbits Gastroenterology 98 1988 787 796
63. A.N. Langnas G.L. Grazi R.J. Stratta Primary sclerosing cholangitis: The emerging role for liver transplantation Am J Gastroenterol 85 1990 1136 1141
64. N.F. LaRusso R.H. Wiesner J. Ludwig Prospective trial of penicillamine in primary sclerosing cholangitis Gastroenterology 95 1988 1036 1042
65. J.G. Lee S.M. Schutz R.E. England Endoscopic therapy of sclerosing cholangitis Hepatology 21 1995 661 667
66. S. Levi A. Urbano-Ispizua R. Gill Multiple K-ras codon 12 mutations in cholangiocarcinoma demonstrated with a sensitive polymerase chain reaction technique Cancer Res 51 1991 3497 3502
67. S.N. Lichtman R.B. Sartor J. Keku Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth Gastroenterology 98 1990 414 423
68. K.D. Lillemoe J.L. Cameron Surgical approaches to primary sclerosing cholangitis Semin Liver Dis 11 1991 49 55
69. K.D. Lindor The Mayo PSC/UDCA study group: Ursodiol for primary sclerosing cholangitis N Engl J Med 336 1997 691 695
70. K.D. Lindor R.A. Jorgensen M.L. Anderson Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: A pilot study Am J Gastroenterol 91 1996 511 515
71. K.D. Lindor R.H. Wiesner J.A. Katzman Lymphocyte subsets in primary sclerosing cholangitis Dig Dis Sci 32 1987 720 725
72. K.D. Lindor R.H. Wiesner N.F. LaRusso Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis Hepatology 7 1987 884 888
73. E.V. Loftus W.J. Sandborn W.J. Tremaine Primary sclerosing cholangitis is associated with nonsmoking: A case-control study Gastroenterology 110 1996 1496 1502
74. E.V. Loftus W.J. Sandborn W.J. Tremaine Risk of colorectal neoplasia in patients with primary sclerosing cholangitis Gastroenterology 110 1996 432 440
75. J. Ludwig Small duct primary sclerosing cholangitis Semin Liver Dis 11 1991 11 17
76. J. Ludwig Surgical pathology of the syndrome of primary sclerosing cholangitis Am J Surg Pathol 13 1989 43 49
77. J. Ludwig S.S. Barham N.F. LaRusso Morphological features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis Hepatology 1 1981 632 640
78. J. Ludwig C.H. Kim R.H. Wiesner Floxuridine induced sclerosing cholangitis: An ischemic cholangiopathy? Hepatology 9 1989 215 218
79. J. Ludwig N.F. LaRusso R.H. Wiesner Primary sclerosing cholangitis Contemp Issues Surg Pathol 8 1986 193 213
80. J. Ludwig N.F. LaRusso R.H. Wiesner The syndrome of primary sclerosing cholangitis Prog Liver Dis 9 1990 556 566
81. R.L. MacCarty N.F. LaRusso R.H. Wiesner Primary sclerosing cholangitis: Findings on cholangiography and pancreatography Radiology 149 1983 39 44
82. C.B. Majoie J.W. Reeders J.B. Sanders Primary sclerosing cholangitis: A modified classification of cholangiographic findings AJR Am J Roentgenol 157 1991 495 497
83. A. Mandal A. Dasgupta L. Jeffers Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium Gastroenterology 106 1994 185 192
84. A.N.B. McNair M. Moloney B.C. Portmann Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases Am J Gastroenterol 93 1998 777 784
85. W.Z. Mehal A.T. Hattersley R.W. Chapman A survey of cytomegalovirus DNA in primary sclerosing cholangitis liver tissue using a sensitive polymerase chain reaction based assay J Hepatol 15 1992 396 399
86. Mehal W.Z. Lo Y.-M.D. B.P. Wordsworth HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis Gastroenterology 106 1994 160 167
87. G.Y. Minuk N. Rascanin R.W. Paul Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis J Hepatol 5 1987 8 13
88. S.P. Mistilis Pericholangitis and ulcerative colitis: Pathology, etiology and pathogenesis Ann Intern Med 63 1965 17 26
89. R. Morecki J.H. Glaser S. Cho Biliary atresia and reovirus type 3 infection N Engl J Med 307 1982 481 484
90. R.N. Myers T.H. Cooper N. Padis Primary sclerosing cholangitis: Complete gross and histological reversal after long term steroid therapy Am J Gastroenterol 53 1970 527 538
91. J.C. Nichols G.J. Gores N.F. LaRusso Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis Mayo Clin Proc 68 1993 874 879
92. O. Olerup R. Olsson R. Hultcrantz HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis Gastroenterology 108 1995 870 878
93. R. Olsson U. Broome A. Danielsson Colchicine treatment of primary sclerosing cholangitis Gastroenterology 108 1995 1199 1203
94. R. Olsson A. Danielsson G. Jarnerot Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis Gastroenterology 100 1991 1319 1323
95. R. Olsson I. Hagerstand U. Broome Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis J Clin Pathol 48 1995 933 935
96. K.R. Palmer B.I. Duerden C.D. Holdsworth Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery Gut 21 1980 851 854
97. R.H. Palmer Bile acids, liver injury and liver disease Arch Intern Med 130 1972 606 617
98. A.D. Perret G. Higgins H.H. Johnson The liver in ulcerative colitis QJM 40 1971 211 238
99. A.D. Perret G. Higgins H.H. Johnson The liver in Crohn's disease QJM 40 1971 187 209
100. H.A. Pitt H.H. Thompson R.K. Tomkins Primary sclerosing cholangitis: Results of an aggressive surgical approach Ann Surg 196 1982 259 268
101. C.I.J. Ponsioen G.N.J. Tytgat Primary sclerosing cholangitis: A clinical review Am J Gastroenterol 93 1998 515 523
102. M.K. Porayko R.H. Wiesner N.F. LaRusso Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease Gastroenterology 98 1990 1594 1602
103. E.J. Prochazka P.I. Terasaki M.S. Park Association of primary sclerosing cholangitis with HLA-Drw52a N Engl J Med 322 1990 1842 1844
104. E.M.M. Quigley N.F. LaRusso J. Ludwig Familial occurrence of primary sclerosing cholangitis and ulcerative colitis Gastroenterology 85 1983 1160 1165
105. M. Rabinovitz A.B. Zajko T. Hassanein Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: A study of 65 patients with bile duct strictures Hepatology 12 1990 747 752
106. M. Radvrer C. Mullen W. Scheithauer Ondansetron for pruritus due to cholestasis N Engl J Med 330 1994 1540
107. J.K. Ramage A. Donaghy J.M. Farrant Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis Gastroenterology 108 1995 865 869
108. H.H. Rasmussen J.F. Fallingborg P.B. Mortensen Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease Scand J Gastroenterol 32 1997 604 610
109. P.M. Rizzi S.D. Ryder B. Portmann Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis Gut 38 1996 265 268
110. S.A. Rogers D.K. Poldolsky Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: An analysis of serological marker CA 19-9 Hepatology 19 1994 543 545
111. C.B. Rosen D.M. Nagorney Cholangiocarcinoma complicating primary sclerosing cholangitis Semin Liver Dis 11 1991 26 30
112. C.B. Rosen D.M. Nagorney R.H. Wiesner Cholangiocarcinoma complicating primary sclerosing cholangitis Ann Surg 213 1991 21 25
113. E. Schrumph K. Elgjo O. Fausa Sclerosing cholangitis in ulcerative colitis Scand J Gastroenterol 15 1980 689 697
114. E. Schrumph O. Fausa O. Forre HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease Scand J Gastroenterol 17 1982 187 191
115. F. Seibold D. Slametschka M. Gregor Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis Gastroenterology 107 1994 532 536
116. F. Seibold P. Weber R. Klein Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis Gut 33 1992 657 662
117. G. Senaldi P.T. Donaldson S. Margin Activation of the complement system in primary sclerosing cholangitis Gastroenterology 97 1989 1430 1434
118. R. Sheng W.L. Campbell A.B. Zajko Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: Evidence of recurrent disease AJR Am J Roentgenol 166 1996 1109 1113
119. R. Sheng A.B. Zajko W.L. Campbell Biliary strictures in hepatic transplants: Prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases AJR Am J Roentgenol 161 1993 297 300
120. H.A. Shephard W.S. Selby R.W.G. Chapman Ulcerative colitis and persistent liver dysfunction QJM 52 1983 503 513
121. J.H. Siegel S. Barnes J.S. Morris Bile acids in liver disease associated with inflammatory bowel disease Digestion 15 1977 469 481
122. J.A. Snook R.W. Chapman G.K. Sachdev Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis J Hepatol 9 1989 36 41
123. M. Steckman D.A. Drossman H.R. Lessene Hepatobiliary disease that precedes ulcerative colitis J Clin Gastroenterol 6 1984 425 428
124. A. Stiehl S. Walker L. Stiehl Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis: A 3 year pilot study with a placebo controlled study period J Hepatol 20 1994 57 64
125. R.W. Stockbrugger R. Olsson B. Jaup Forty six patients with primary sclerosing cholangitis: Radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease Hepatogastroenterology 35 1988 289 294
126. G.H. Thomas Ulceration of the colon with enlarged fatty liver Trans Pathol Soc Philadelphia 4 1874 87
127. H.H. Thompson H.A. Pitt K.J. Lewin Sclerosing cholangitis and histiocytosis X Gut: 25 1984 526 530
128. Van Erpecum K.J. S.J.H.M. Smits Van De Meeberg P.C. Risk of primary sclerosing cholangitis is associated with nonsmoking behavior Gastroenterology 110 1996 1503 1506
129. Van Milligen de Wit A.W.M. Van Bracht J. E.A.J. Rauws Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis Gastrointest Endosc 44 1996 293 299
130. Van Milligen de Wit A.W.M. E.A.J. Rauws J. Bracht Lack of complications following short term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis Gastrointest Endosc 46 1997 344 347
131. Van Thiel D.H. P. Carroll K. Abu-Elmagd Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: Results of an open-label preliminary trial Am J Gastroenterol 90 1995 455 459
132. V. Vilgrain S. Erlinger J. Belhgiti Cholangiographic appearance simulating sclerosing cholangitis in metastatic adenocarcinoma of the liver Gastroenterology 99 1990 850 853
133. I.E. Vinnik F. Kern Struthers J.E. Jr Experimental chronic portal vein bacteremia Proc Soc Exp Biol Med 115 1964 311 314
134. A. Wee J. Ludwig Pericholangitis in chronic ulcerative colitis: Primary sclerosing cholangitis of the small bile ducts? Ann Intern Med 102 1985 581 587
135. T.L. Whiteside S. Lasky L. Si Immunological analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis Hepatology 5 1985 468 474
136. R.H. Wiesner Current concepts in primary sclerosing cholangitis Mayo Clin Proc 69 1994 969 982
137. R.H. Wiesner P.M. Grambsch E.R. Dickson Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis Hepatology 10 1989 430 436
138. Wiesner R.H. La Russo N.F. Clinicopathologic features of the syndrome of primary sclerosing cholangitis Gastroenterology 79 1980 200 206
139. R.H. Wiesner N.F. LaRusso R.R. Dozois Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis Gastroenterology 90 1986 316 322
140. L. Young-Mee M.M. Kaplan Primary sclerosing cholangitis N Engl J Med 332 1995 924 933